Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. / Hansson, Karin; Radke, Katarzyna; Aaltonen, Kristina; Saarela, Jani; Mañas, Adriana; Sjölund, Jonas; Smith, Emma M.; Pietras, Kristian; Påhlman, Sven; Wennerberg, Krister; Gisselsson, David; Bexell, Daniel.

In: Science Translational Medicine, Vol. 12, No. 562, eaba4434, 2020, p. 1-17.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansson, K, Radke, K, Aaltonen, K, Saarela, J, Mañas, A, Sjölund, J, Smith, EM, Pietras, K, Påhlman, S, Wennerberg, K, Gisselsson, D & Bexell, D 2020, 'Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma', Science Translational Medicine, vol. 12, no. 562, eaba4434, pp. 1-17. https://doi.org/10.1126/scitranslmed.aba4434

APA

Hansson, K., Radke, K., Aaltonen, K., Saarela, J., Mañas, A., Sjölund, J., Smith, E. M., Pietras, K., Påhlman, S., Wennerberg, K., Gisselsson, D., & Bexell, D. (2020). Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science Translational Medicine, 12(562), 1-17. [eaba4434]. https://doi.org/10.1126/scitranslmed.aba4434

Vancouver

Hansson K, Radke K, Aaltonen K, Saarela J, Mañas A, Sjölund J et al. Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science Translational Medicine. 2020;12(562):1-17. eaba4434. https://doi.org/10.1126/scitranslmed.aba4434

Author

Hansson, Karin ; Radke, Katarzyna ; Aaltonen, Kristina ; Saarela, Jani ; Mañas, Adriana ; Sjölund, Jonas ; Smith, Emma M. ; Pietras, Kristian ; Påhlman, Sven ; Wennerberg, Krister ; Gisselsson, David ; Bexell, Daniel. / Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. In: Science Translational Medicine. 2020 ; Vol. 12, No. 562. pp. 1-17.

Bibtex

@article{12a27a363919498aa28ebc77a95d15b0,
title = "Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma",
author = "Karin Hansson and Katarzyna Radke and Kristina Aaltonen and Jani Saarela and Adriana Ma{\~n}as and Jonas Sj{\"o}lund and Smith, {Emma M.} and Kristian Pietras and Sven P{\aa}hlman and Krister Wennerberg and David Gisselsson and Daniel Bexell",
year = "2020",
doi = "10.1126/scitranslmed.aba4434",
language = "English",
volume = "12",
pages = "1--17",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "american association for the advancement of science",
number = "562",

}

RIS

TY - JOUR

T1 - Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

AU - Hansson, Karin

AU - Radke, Katarzyna

AU - Aaltonen, Kristina

AU - Saarela, Jani

AU - Mañas, Adriana

AU - Sjölund, Jonas

AU - Smith, Emma M.

AU - Pietras, Kristian

AU - Påhlman, Sven

AU - Wennerberg, Krister

AU - Gisselsson, David

AU - Bexell, Daniel

PY - 2020

Y1 - 2020

U2 - 10.1126/scitranslmed.aba4434

DO - 10.1126/scitranslmed.aba4434

M3 - Journal article

C2 - 32967973

VL - 12

SP - 1

EP - 17

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 562

M1 - eaba4434

ER -

ID: 249861390